99 related articles for article (PubMed ID: 11346356)
1. Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifestation of the immune restoration syndrome.
Silvestre JF; Albares MP; Ramón R; Botella R
Arch Dermatol; 2001 May; 137(5):669-70. PubMed ID: 11346356
[No Abstract] [Full Text] [Related]
2. Cutaneous Mycobacterium avium complex infection as a manifestation of the immune reconstitution syndrome in a human immunodeficiency virus-infected child.
Steenhoff AP; Wood SM; Shah SS; Rutstein RM
Pediatr Infect Dis J; 2007 Aug; 26(8):755-7. PubMed ID: 17848894
[TBL] [Abstract][Full Text] [Related]
3. Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection: a manifestation of immune restoration.
Chamberlain AJ; Hollowood K; Turner RJ; Byren I
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S161-5. PubMed ID: 15577760
[TBL] [Abstract][Full Text] [Related]
4. Extensive development of flat warts as a cutaneous manifestation of immune reconstitution syndrome.
Iarikov D; Duke W; Skiest D
AIDS Read; 2008 Oct; 18(10):524-7. PubMed ID: 18975443
[TBL] [Abstract][Full Text] [Related]
5. Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome.
Visco-Comandini U; Longo B; Cuzzi T; Paglia MG; Antonucci G
Scand J Infect Dis; 2004; 36(11-12):881-3. PubMed ID: 15764179
[TBL] [Abstract][Full Text] [Related]
6. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.
Posada-Vergara MP; Lindoso JA; Tolezano JE; Pereira-Chioccola VL; Silva MV; Goto H
J Infect Dis; 2005 Nov; 192(10):1819-22. PubMed ID: 16235183
[TBL] [Abstract][Full Text] [Related]
7. Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.
Ghosn J; Paris L; Ajzenberg D; Carcelain G; Dardé ML; Tubiana R; Bossi P; Bricaire F; Katlama C
Clin Infect Dis; 2003 Oct; 37(7):e112-4. PubMed ID: 13130422
[TBL] [Abstract][Full Text] [Related]
8. A case of efflorescence of cutaneous warts as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected patient.
Kerob D; Dupuy A; Vignon-Pennamen MD; Bournerias I; Dohin E; Lebbe C
Clin Infect Dis; 2007 Aug; 45(3):405-6. PubMed ID: 17599331
[No Abstract] [Full Text] [Related]
9. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
Kong HH; Myers SA
Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous and pulmonary sarcoidosis in a patient with human immunodeficiency virus: a late feature of immune restoration syndrome.
Martí N; Martin JM; Mayordomo E; Calduch L; Jordá E
Clin Exp Dermatol; 2011 Apr; 36(3):306-7. PubMed ID: 20846355
[No Abstract] [Full Text] [Related]
11. Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection.
Gilad J; Borer A; Hallel-Halevy D; Riesenberg K; Alkan M; Schlaeffer F
Isr Med Assoc J; 2001 Jun; 3(6):451-2. PubMed ID: 11433642
[No Abstract] [Full Text] [Related]
12. Peyronie's disease in men with HIV responding to highly active antiretroviral therapy.
Rogers GD; French MA
HIV Med; 2004 May; 5(3):185-6. PubMed ID: 15139986
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution associated hypercalcemia.
Tsao YT; Wu YC; Yang CS; Lin YT
Am J Emerg Med; 2009 Jun; 27(5):629.e1-3. PubMed ID: 19497480
[TBL] [Abstract][Full Text] [Related]
14. Concurrent granulomatous Pneumocystis carinii and Mycobacterium xenopi pneumonia: an unusual manifestation of HIV immune reconstitution disease.
Chen F; Sethi G; Goldin R; Wright AR; Lacey CJ
Thorax; 2004 Nov; 59(11):997-9. PubMed ID: 15516479
[TBL] [Abstract][Full Text] [Related]
15. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution.
Safdar A; Rubocki RJ; Horvath JA; Narayan KK; Waldron RL
Clin Infect Dis; 2002 Nov; 35(10):1250-7. PubMed ID: 12410486
[TBL] [Abstract][Full Text] [Related]
16. Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration.
Lanzafame M; Faggian F; Lattuada E; Antolini D; Vento S
J Infect Dis; 2005 Mar; 191(6):1027. PubMed ID: 15717283
[No Abstract] [Full Text] [Related]
17. Rheumatic manifestations of human immunodeficiency virus infection.
Louthrenoo W
Curr Opin Rheumatol; 2008 Jan; 20(1):92-9. PubMed ID: 18281864
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy per se decreased mortality and morbidity of advanced human immunodeficiency virus disease in Hong Kong.
Chan CW; Cheng LS; Chan WK; Wong KH
Chin Med J (Engl); 2005 Aug; 118(16):1338-45. PubMed ID: 16157027
[TBL] [Abstract][Full Text] [Related]
19. Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy.
Stone SF; Price P; Brochier J; French MA
J Infect Dis; 2001 Oct; 184(8):1073-7. PubMed ID: 11574925
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy.
Aaron L; Lidove O; Yousry C; Roudiere L; Dupont B; Viard JP
Clin Infect Dis; 2002 Oct; 35(7):880-2. PubMed ID: 12228826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
